Copyright
©The Author(s) 2015.
World J Cardiol. Oct 26, 2015; 7(10): 609-620
Published online Oct 26, 2015. doi: 10.4330/wjc.v7.i10.609
Published online Oct 26, 2015. doi: 10.4330/wjc.v7.i10.609
Figure 5 Relevance of measuring of lipoprotein-associated phospholipase A2 activity for risk stratification in adult patients with moderate cardiovascular risk (> 2 risk factors) or higher[80].
Lp-PLA2: Lipoprotein-associated phospholipase A2; LDL: Low-density lipoprotein; CAD: Coronary artery disease; CV: Cardiovascular.
- Citation: Maiolino G, Bisogni V, Rossitto G, Rossi GP. Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications. World J Cardiol 2015; 7(10): 609-620
- URL: https://www.wjgnet.com/1949-8462/full/v7/i10/609.htm
- DOI: https://dx.doi.org/10.4330/wjc.v7.i10.609